|Articles|September 4, 2018
SGS Implements PBMC Analysis for Early Phase Clinical Trials
Advertisement
SGS, a life sciences, pharmaceutical, clinical, and bioanalytical contract solutions provider, announced that it has successfully implemented advanced techniques for the collection and use of peripheral blood mononuclear cells for early phase clinical trials at its Clinical Pharmacology Unit in Antwerp, Belgium.
Read the full release
Newsletter
Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
FDA Approves UCB’s Kygevi for TK2 Deficiency Based on Multi-Study Clinical Program Demonstrating Significant Survival and Motor Gains
2
Inside the Recruitment Bottlenecks Driving Trial Delays
3
Designing Feasible Protocols with Real-World Data
4
Eli Lilly’s Phase II Trial of Eloralintide Shows Up to 20% Weight Reduction in Adults With Obesity
5
.png "BioPharm International")
.png "Pharmaceutical Commerce"){kind=logo}
.png "Turbo Machinery Magazine")
.png){kind=spacer}
